BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2021 9:54:22 AM | Browse: 340 | Download: 729
 |
Received |
|
2021-02-24 12:32 |
|
Peer-Review Started |
|
2021-02-24 12:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-03 00:54 |
|
Revised |
|
2021-06-06 18:17 |
|
Second Decision |
|
2021-10-13 06:20 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-10-14 03:02 |
|
Articles in Press |
|
2021-10-14 03:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-10-05 01:32 |
|
Typeset the Manuscript |
|
2021-11-19 01:07 |
|
Publish the Manuscript Online |
|
2021-11-24 09:54 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo and Francisco Javier Bosques-Padilla |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Francisco Javier Bosques-Padilla, PhD, Full Professor, Centro Regional para el Estudio de las Enfermedades Digestivas, Servicio de Gastroenterología, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Ave. Madero y Gonzalitos S/N, Col. Mitras, Monterrey 64460, Mexico. fbosques58@hotmail.com |
| Key Words |
Fatty liver; Biomarkers; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis |
| Core Tip |
Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence worldwide. Liver biopsy is considered the gold standard for diagnosis, but it has several limitations. Given the burden on the healthcare system caused by liver fibrosis in a population with metabolic syndrome, there is a priority for noninvasive and accurate diagnostic biomarkers that differentiate patients with steatosis from those with NASH, stage fibrosis, predict progression, and monitor treatment response. These biomarkers could assist clinicians in early interventions, avoiding complications, and improving prognosis. Here, we summarize the current evidence and future directions. |
| Publish Date |
2021-11-24 09:54 |
| Citation |
Castillo-Castro C, Martagón-Rosado AJ, Ortiz-Lopez R, Garrido-Treviño LF, Villegas-Albo M, Bosques-Padilla FJ. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World J Hepatol 2021; 13(11): 1494-1511 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i11/1494.htm |
| DOI |
https://dx.doi.org/ 10.4254/wjh.v13.i11.1494 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
